Premium
Global private equity firm KKR’s deal to acquire a controlling stake in JB Chemicals & Pharmaceuticals Ltd values the company at a discount to other listed firms in India operating in the segment. Under the deal, KKR may eventually own up to 64.95% stake by shelling out a total of Rs ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
